Murine antithymocyte globulin therapy alters disease progression in NOD mice by a time-dependent induction of immunoregulation

Diabetes

Volumn 57, Issue 2, 2008, Pages 405-414

  Simon, Greg ^a   Parker, Matthew ^a   Ramiya, Vijayakumar ^b   Wasserfall, Clive ^a   Huang, Yanfei ^b   Bresson, Damien ^c   Schwartz, R Fletcher ^a   Campbell Thompson, Martha ^a   Tenace, Lauren ^a   Brusko, Todd ^a   Xue, Song ^b   Scaria, Abraham ^d   Lukason, Michael ^d   Eisenbeis, Scott ^d   Williams, John ^d   Clare Salzler, Michael ^a   Schatz, Desmond ^b   Kaplan, Bruce ^e   Von Herrath, Matthias ^c   Womer, Karl ^b   Atkinson, Mark A ^a   more..

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^d GENZYME CORPORATION   (United States)

^e UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THYMOCYTE ANTIBODY; CYTOKINE; LYMPHOCYTE ANTIBODY;

ADOPTIVE TRANSFER; AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL ACTIVITY; CONTROLLED STUDY; DISEASE COURSE; DOSE TIME EFFECT RELATION; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; FEMALE; GLUCOSE METABOLISM; IMMUNOMODULATION; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO CULTURE; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; LYMPH NODE; LYMPHOCYTE DEPLETION; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPLEEN; SPLEEN CELL; ANIMAL; ANTIBODY PRODUCTION; BAGG ALBINO MOUSE; BLOOD; FLOW CYTOMETRY; GLUCOSE TOLERANCE TEST; IMMUNOLOGY; LYMPHOCYTE; RABBIT; T LYMPHOCYTE;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODY FORMATION; ANTILYMPHOCYTE SERUM; CYTOKINES; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; FLOW CYTOMETRY; GLUCOSE TOLERANCE TEST; LYMPHOCYTES; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; RABBITS; T-LYMPHOCYTES;

EID: 40749153195     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db06-1384     Document Type: Article

References (43)

1. Atkinson MA, Eisenbarth GS: Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 358:221-229, 2001
2. Graca L, Le Moine A, Cobbold SP, Waldmann H: Antibody-induced transplantation tolerance: the role of dominant regulation. Immunol Res 28:181-191, 2003
3. Harlan DM, von Herrath M: Immune intervention with anti-CD3 in diabetes. Nat Med 11:716-718, 2005
4. Pescovitz MD: Rituximab, an anti-cd20 monoclonal antibody: history and mechanism of action. Am J Transplant 6:859-866, 2006
5. Chatenoud L: Monoclonal antibody-based strategies in autoimmunity and transplantation. Methods Mol Med 109:297-328, 2005
6. Chatenoud L, Thervet E, Primo J, Bach JF: Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc Natl Acad SciUSA91:123-127, 1994
7. Belghith M, Bluestone JA, Barriot S, Megret J, Bach JF, Chatenoud L: TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat Med 9:1202-1208, 2003
8. Chatenoud L: CD3 antibody treatment stimulates the functional capability of regulatory T-cells. Novartis Found Symp 252:279-286, 2003 [discussion 286-290]
9. Herold KC, Hagopian W, Auger JA, Poumian-Ruiz E, Taylor L, Donaldson D, Gitelman SE, Harlan DM, Xu D, Zivin RA, Bluestone JA: Anti-CD3 monoclonal ntibody in new-onset type 1 diabetes mellitus. NEngl J Med 346:1692-1698, 2002
10. Keymeulen B, Vandemeulebroucke E, Ziegler AG, Mathieu C, Kaufman L, Hale G, Gorus F, Goldman M, Walter M, Candon S, Schandene L, Crenier L, De Block C, Seigneurin JM, De Pauw P, Pierard D, Weets I, Rebello P, Bird P, Berrie E, Frewin M, Waldmann H, Bach JF, Pipeleers D, Chatenoud L: Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med 352:2598-2608, 2005
11. Like AA, Rossini AA, Guberski DL, Appel MC, Williams RM: Spontaneous diabetes mellitus: reversal and prevention in the BB/W rat with antiserum to rat lymphocytes. Science 206:1421-1423, 1979
12. Maki T, Ichikawa T, Blanco R, Porter J: Long-term abrogation of autoimmune diabetes in nonobese diabetic mice by immunotherapy with anti-lymphocyte serum. Proc Natl Acad Sci USA 89:3434-3438, 1992
13. Ogawa N, List JF, Habener JF, Maki T: Cure of overt diabetes in NOD mice by transient treatment with anti-lymphocyte serum and exendin-4. Diabetes 53:1700-1705, 2004
14. Smith JM, Nemeth TL, McDonald RA: Current immunosuppressive agents: efficacy, side effects, and utilization. Pediatr Clin North Am 50:1283-1300, 2003
15. Nashan B: Antibody induction therapy in renal transplant patients receiving calcineurin-inhibitor immunosuppressive regimens: a comparative review. Bio Drugs 19:39 -46, 2005
16. Bevans MF, Shalabi RA: Management of patients receiving antithymocyte globulin for aplastic anemia and myelodysplastic syndrome. Clin J Oncol Nurs 8:377-382, 2004
17. Bacigalupo A: Antithymocyte globulin for prevention of graft-versus-host disease. Curr Opin Hematol 12:457-462, 2005
18. Sakaguchi S, Sakaguchi N, Shimizu J, Yamazaki S, Sakihama T, Itoh M, Kuniyasu Y, Nomura T, Toda M, Takahashi T: Immunologic tolerance maintained by CD25+ CD4+ regulatory T-cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 182:18-32, 2001
19. Ziegler SF: FOXP3: of mice and men. Annu Rev Immunol 24:209 -226, 2006
20. Goudy KS, Burkhardt BR, Wasserfall C, Song S, Campbell-Thompson ML, Brusko T, Powers MA, Clare-Salzler MJ, Sobel ES, Ellis TM, Flotte TR, Atkinson MA: Systemic overexpression of IL-10 induces CD4+ CD25+ cell populations in vivo and ameliorates type 1 diabetes in nonobese diabetic mice in a dose-dependent fashion. J Immunol 171:2270-2278, 2003
21. Atkinson MA, Leiter EH: The NOD mouse model of type 1 diabetes: as good as it gets? Nat Med 5:601-604, 1999
22. Luo X, Tarbell KV, Yang H, Pothoven K, Bailey SL, Ding R, Steinman RM, Suthanthiran M: Dendritic cells with TGF-beta1 differentiate naive CD4+ CD25- T-cells into islet-protective Foxp3+ regulatory T-cells. Proc Natl Acad Sci USA104:2821-2826, 2007
23. Baecher-Allan C, Wolf E, Hafler DA: Functional analysis of highly defined, FACS-isolated populations of human regulatory CD4+ CD25+ T-cells. Clin Immunol 115:10-18, 2005
24. Salomon B, Lenschow DJ, Rhee L, Ashourian N, Singh B, Sharpe A, Bluestone JA: B7/CD28 costimulation is essential for the homeostasis of the CD4+ CD25+ immunoregulatory T-cells that control autoimmune diabetes. Immunity 12:431-440, 2000
25. Weber SE, Harbertson J, Godebu E, Mros GA, Padrick RC, Carson BD, Ziegler SF, Bradley LM: Adaptive islet-specific regulatory CD4 T-cells control autoimmune diabetes and mediate the disappearance of pathogenic Th1 cells in vivo. J Immunol 176:4730-4739, 2006
26. Chen Z, Herman AE, Matos M, Mathis D, Benoist C: Where CD4+ CD25+ Treg cells impinge on autoimmune diabetes. J Exp Med 202:1387-1397, 2005
27. Ott PA, Anderson MR, Tary-Lehmann M, Lehmann PV: CD4+ CD25+ regulatory T-cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes. Cell Immunol 235:1-11, 2005
28. You S, Belghith M, Cobbold S, Alyanakian MA, Gouarin C, Barriot S, Garcia C, Waldmann H, Bach JF, Chatenoud L: Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cells. Diabetes 54:1415-1422, 2005
29. Monaco AP, Wood ML: Models of specific unresponsiveness in adult animals: potential clinical application. Transplant Proc 13:547-555, 1981
30. Michallet MC, Preville X, Flacher M, Fournel S, Genestier L, Revillard JP: Functional antibodies to leukocyte adhesion molecules in antithymocyte globulins. Transplantation 75:657-662, 2003
31. Michallet MC, Saltel F, Preville X, Flacher M, Revillard JP, Genestier L: Cathepsin-B-dependent apoptosis triggered by antithymocyte globulins: a novel mechanism of T-cell depletion. Blood 102:3719-3726, 2003
32. Zand MS, Vo T, Huggins J, Felgar R, Liesveld J, Pellegrin T, Bozorgzadeh A, Sanz I, Briggs BJ: Polyclonal rabbit antithymocyte globulin triggers B-cell and plasma cell apoptosis by multiple pathways. Transplantation 79:1507-1515, 2005
33. Monti P, Allavena P, Di Carlo V, Piemonti L: Effects of anti-lymphocytes and anti-thymocytes globulin on human dendritic cells. Int Immunopharmacol 3:189-196, 2003
34. Ferran C, Dy M, Sheehan K, Merite S, Schreiber R, Landais P, Grau G, Bluestone J, Bach JF, Chatenoud L: Inter-mouse strain differences in the in vivo anti-CD3 induced cytokine release. Clin Exp Immunol 86:537-543, 1991
35. Hirsch R, Bluestone JA, DeNenno L, Gress RE: Anti-CD3 F(ab′)2 fragments are immunosuppressive in vivo without evoking either the strong humoral response or morbidity associated with whole mAb. Transplantation 49:1117-1123, 1990
36. Chatenoud L: Use of CD3 antibodies in transplantation and autoimmune diseases. Transplant Proc 26:3191-3193, 1994
37. Putnam AL, Vendrame F, Dotta F, Gottlieb PA: CD4+ CD25 high regulatory T-cells in human autoimmune diabetes. J Autoimmun 24:55-62, 2005
38. + T-cells in type 1 diabetes. Diabetes 54:1407-1414, 2005
39. Lindley S, Dayan CM, Bishop A, Roep BO, Peakman M, Tree TI: Defective suppressor function in CD4(+ )CD25(+ ) T-cells from patients with type 1 diabetes. Diabetes 54:92-99, 2005
40. Kukreja A, Cost G, Marker J, Zhang C, Sun Z, Lin-Su K, Ten S, Sanz M, Exley M, Wilson B, Porcelli S, Maclaren N: Multiple immuno-regulatory defects in type-1 diabetes. J Clin Invest 109:131-140, 2002
41. Makhlouf L, Grey ST, Dong V, Csizmadia E, Arvelo MB, Auchincloss H Jr, Ferran C, Sayegh MH: Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice. Transplantation 77:990-997, 2004
42. Brennan DC, Flavin K, Lowell JA, Howard TK, Shenoy S, Burgess S, Dolan S, Kano JM, Mahon M, Schnitzler MA, Woodward R, Irish W, Singer GG: A randomized, double-blinded comparison of thymoglobulin versus atgam for induction immunosuppressive therapy in adult renal transplant recipients. Transplantation 67:1011-1018, 1999
43. Goudy K, Song S, Wasserfall C, Zhang YC, Kapturczak M, Muir A, Powers M, Scott-Jorgensen M, Campbell-Thompson M, Crawford JM, Ellis TM, Flotte TR, Atkinson MA: Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice. Proc Natl Acad Sci U SA 98:13913-13918, 2001